Dulal, Pawan
Gharaei, Robabeh
Berg, Adam
Walters, Adam A.
Hawkins, Nicholas
Claridge, Tim D. W.
Kowal, Katarzyna
Neill, Steven
Ritchie, Adam J.
Ashfield, Rebecca
Hill, Adrian V. S.
Tronci, Giuseppe
Russell, Stephen J.
Douglas, Alexander D.
Funding for this research was provided by:
Medical Research Council (MC_PC_15040, MR/P017339/1, MC_PC_15040, MR/P017339/1)
Biotechnology and Biological Sciences Research Council (BB/M019152/1)
Engineering and Physical Sciences Research Council (EP/R013756/1)
Wellcome Trust (104750/Z/14, 201477/Z/16/Z)
Article History
Received: 24 May 2021
Accepted: 23 September 2021
First Online: 22 October 2021
Change Date: 29 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-02406-9
Competing interests
: AVSH and ADD are named inventors on patents relating to adenovirus-vectored vaccines.